| SLE (N = 15,961, PY = 89,256) | PM/DM (N = 2270, PY = 10,252) | SSc (N = 2071, PY = 10,868) | RA (N = 38,355, PY = 22,7549) | pSS (N = 18,309, PY = 81,995) | |||||
---|---|---|---|---|---|---|---|---|---|---|
Events | IR (95% CI) | Events | IR (95% CI) | Events | IR (95% CI) | Events | IR (95% CI) | Events | IR (95% CI) | |
Fungus | ||||||||||
 Aspergillus | 16 | 0.18 (0.10–0.29) | 6 | 0.59 (0.22–1.27) | 1 | 0.09 (0.01–0.51) | 22 | 0.10 (0.06–0.15) | 5 | 0.06 (0.02–0.14) |
 Candidiasis | 388 | 4.35 (3.93–4.80) | 85 | 8.29 (6.62–10.25) | 49 | 4.51 (3.34–5.96) | 426 | 1.87 (1.70–2.06) | 145 | 1.77 (1.49–2.08) |
 Cryptococcus | 39 | 0.44 (0.31–0.60) | 9 | 0.88 (0.40–1.67) | 2 | 0.18 (0.02–0.67) | 45 | 0.20 (0.14–0.27) | 14 | 0.17 (0.09–0.29) |
 PJP | 45 | 0.51 (0.37–0.67) | 18 | 1.76 (1.04–2.78) | 4 | 0.37 (0.10–0.94) | 18 | 0.08 (0.05–0.13) | 9 | 0.11 (0.05–0.21) |
 Subtotal | 488 | 5.48 (4.99–5.98) | 118 | 11.5 (9.53–13.8) | 56 | 5.15 (3.89–6.69) | 511 | 2.25 (2.06–2.45) | 173 | 2.11 (1.81–2.45) |
CMV | 100 | 1.12 (0.91–1.37) | 18 | 1.76 (1.04–2.78) | 4 | 0.37 (0.10–0.94) | 29 | 0.13 (0.09–0.18) | 15 | 0.18 (0.10–0.30) |
Salmonellosis | 272 | 3.05 (2.70–3.43) | 30 | 2.93 (1.97–4.18) | 11 | 1.01 (0.51–1.81) | 118 | 0.52 (0.43–0.62) | 27 | 0.33 (0.22–0.48) |
Herpes zoster | 2580 | 28.9 (27.8–30.0) | 377 | 36.8 (33.2–40.7) | 216 | 19.9 (17.3–22.7) | 4084 | 17.9 (17.4–18.5) | 1502 | 18.3 (17.4–19.3) |
TB | 341 | 3.82 (3.43–4.25) | 71 | 6.93 (5.41–8.74) | 47 | 4.32 (3.18–5.75) | 839 | 3.69 (3.44–3.95) | 213 | 2.60 (2.26–2.97) |
NTM | 63 | 0.71 (0.54–0.90) | 14 | 1.37 (0.75–2.29) | 9 | 0.82 (0.38–1.57) | 121 | 0.53 (0.44–0.64) | 48 | 0.59 (0.43–0.78) |
Non-herpes zoster infection | 1264 | 14.2 (13.4–15.0) | 251 | 24.5 (21.6–27.7) | 127 | 11.7 (9.74–13.9) | 1617 | 7.10 (6.76–7.40) | 476 | 5.81 (5.30–6.35) |
Total | 3844 | 43.1 (41.7–44.5) | 628 | 61.3 (56.6–66.2) | 343 | 31.6 (28.3–35.1) | 5701 | 25.0 (24.4–25.7) | 1978 | 24.1 (23.1–25.2) |